You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (67)

Journals (0)

1-10 of 67 results for HR /HER2− advanced breast cancer

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Economic Evaluation of Inavolisib Combined With Palbociclib–Fulvestrant for PIK3CA-Mutated,HR+/HER2− Advanced Breast Cancer in USA

Open access

Research article

First published 2026

Economic Evaluation of Inavolisib Combined With Palbociclib–Fulvestrant for PIK3CA-Mutated,HR+/HER2− Advanced Breast Cancer in USA

Hanqing Zeng, Li-Ying Song, Ren Guo [...]

Technology in Cancer Research & Treatment

Select article: Ribociclib in HR+/HER2− Advanced or Metastatic Breast Cancer Patients

Retricted access

Review article

First published 2019-5

Ribociclib in HR+/HER2− Advanced or Metastatic Breast Cancer Patients

Kaitlin Rascon, Goran Flajc, Carmine De Angelis [...]

Annals of Pharmacotherapy

Select article: Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer

Open access

Review article

First published 2024

Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer

Sijia Wu, Junnan Xu, Yiwen Ma [...]

Therapeutic Advances in Medical Oncology

Select article: Endocrine therapy plus HER2-targeted therapy,another favorable option for HR+/HER2+ advanced breast cancer patients

Open access

Review article

First published 2024

Endocrine therapy plus HER2-targeted therapy,another favorable option for HR+/HER2+ advanced breast cancer patients

Yuehua Liang, Xiaoran Liu, Zehui Yun [...]

Therapeutic Advances in Medical Oncology

Select article: Dalpiciclib in combination with letrozole/anastrozole or fulvestrant in HR-positive and HER2-negative advanced breast cancer: results from a phase Ib study

Open access

Research article

First published 2024

Dalpiciclib in combination with letrozole/anastrozole or fulvestrant in HR-positive and HER2-negative advanced breast cancer: results from a phase Ib study

Qingyuan Zhang, Pin Zhang, Min Yan [...]

Therapeutic Advances in Medical Oncology

Select article: Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer

Open access

Review article

First published 2021

Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer

Huimin Lv, Min Yan, Zefei Jiang

Therapeutic Advances in Medical Oncology

Select article: Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: a matching-adjusted indirect comparison

Open access

Research article

First published 2023

Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: a matching-adjusted indirect comparison

Hope S. Rugo, Victoria Harmer, Joyce O’Shaughnessy [...]

Therapeutic Advances in Medical Oncology

Select article: Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2− advanced breast cancer: a Brazilian public health care system perspective

Open access

Research article

First published 2022

Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2− advanced breast cancer: a Brazilian public health care system perspective

Daniela Dornelles Rosa, Carlos Alberto da Silva Magliano, Sergio D. Simon [...]

Therapeutic Advances in Medical Oncology

Select article: MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study

Open access

Research article

First published 2020

MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study

Qing Yuan Zhang, Tao Sun, Yong Mei Yin [...]

Therapeutic Advances in Medical Oncology

Select article: Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2− advanced breast cancer

Open access

Research article

First published 2022

Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2− advanced breast cancer

Debu Tripathy, Tristan Curteis, Sara Hurvitz [...]

Therapeutic Advances in Medical Oncology

1
2
3
•••
7
10 / page

Article type

Publication date

Subjects

Access